Cite
Loss of compensatory pro-survival and anti-apoptotic modulator, IKKε, sensitizes ovarian cancer cells to CHEK1 loss through an increased level of p21
MLA
George E. Wright, et al. “Loss of Compensatory Pro-Survival and Anti-Apoptotic Modulator, IKKε, Sensitizes Ovarian Cancer Cells to CHEK1 Loss through an Increased Level of P21.” Oncotarget, vol. 5, Nov. 2014, pp. 12788–802. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ef0d9c853b9fe766f8e6469e22fa7c90&authtype=sso&custid=ns315887.
APA
George E. Wright, Marianne K. Kim, Ian S. Goldlust, Dong J. Min, & Christina M. Annunziata. (2014). Loss of compensatory pro-survival and anti-apoptotic modulator, IKKε, sensitizes ovarian cancer cells to CHEK1 loss through an increased level of p21. Oncotarget, 5, 12788–12802.
Chicago
George E. Wright, Marianne K. Kim, Ian S. Goldlust, Dong J. Min, and Christina M. Annunziata. 2014. “Loss of Compensatory Pro-Survival and Anti-Apoptotic Modulator, IKKε, Sensitizes Ovarian Cancer Cells to CHEK1 Loss through an Increased Level of P21.” Oncotarget 5 (November): 12788–802. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ef0d9c853b9fe766f8e6469e22fa7c90&authtype=sso&custid=ns315887.